
The efficacy of zzso gastric bypass zzso to control type 2 diabetes zzso zzso has been demonstrated in zzso obese zzso zzso procedures primarily focused on zzso control in patients with body mass index zzso zzso have shown to effectively induce zzso of zzso However, only few reports have evaluated the safety and efficacy of zzso in this group of zzso The aim of this study is to assess the safety and efficacy of zzso in zzso patients with zzso zzso All zzso patients with zzso zzso and at least 12 months of follow-up who underwent zzso zzso were zzso Safety of the procedure was evaluated according to zzso need of zzso and complication zzso zzso parameters were evaluated at baseline and 6, 12, and 24 months after zzso Thirty patients were zzso zzso zzso were zzso Age, zzso and duration of diabetes were zzso years, zzso zzso zzso years, zzso No mortality was zzso No zzso was zzso Average length of stay was zzso zzso Early and late zzso complications were observed in five zzso and five zzso patients, zzso Twelve months after surgery, zzso was observed in 25 of 30 patients zzso After 2 years, zzso was achieved in 13 of 20 patients zzso and zzso zzso decreased from zzso to zzso and zzso model assessment of insulin resistance from zzso to zzso after 12 zzso zzso is a safe and effective procedure to induce zzso zzso in otherwise not eligible patients for zzso zzso Evidence from prospective studies is needed to validate this zzso 

